Amherst, MA, United States of America

Kingshuk Dutta

This inventor holds 2 USPTO granted patents. Top assignee: University of Massachusetts. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kingshuk Dutta. Retrieved from https://idiyas.com/inventor/kingshuk-dutta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Kingshuk Dutta

Introduction

Kingshuk Dutta is a prominent inventor based in Amherst, MA (US). He has made significant contributions to the field of nucleic acid delivery systems. With a total of 2 patents, his work focuses on novel approaches to enhance the effectiveness of nucleic acid therapies.

Latest Patents

Dutta's latest patents include advancements in lipid-polymer based complexation and delivery of nucleic acids. These inventions provide novel polymers and crosslinked polymer-nucleic acid complexes. They also introduce lipid-polymer-nucleic acid-based complexation and nanoassemblies. Furthermore, his work emphasizes nanoassembly-based intracellular delivery of nucleic acids and controlled release upon degradation in response to specific microenvironments within cells. The compositions and methods of preparation and use of these innovations are also detailed in his patents.

Career Highlights

Kingshuk Dutta is affiliated with the University of Massachusetts, where he continues to push the boundaries of research in his field. His work has garnered attention for its potential applications in medical therapies and biotechnology.

Collaborations

Dutta collaborates with Sankaran Thayumanavan, enhancing the scope and impact of their research endeavors.

Conclusion

Kingshuk Dutta's innovative work in nucleic acid delivery systems showcases his commitment to advancing medical science. His contributions are paving the way for future breakthroughs in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…